BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND CALR, ENSG00000179218, 811, P27797, SSA, RO, FLJ26680, cC1qR
245 results:

  • 1. Safety and efficacy of nivolumab in elderly patients with metastatic clear cell renal cell carcinoma: Analysis of the NIVOREN GETUG-AFU 26 study.
    Mourey L; Rainho LT; Dalban C; Carril-Ajuria L; Negrier S; Chevreau C; Gravis G; Thibault C; Laguerre B; Barthelemy P; Borchiellini D; Gross-Goupil M; Geoffrois L; Rolland F; Thiery-Vuillemin A; Tantot F; Chaput N; Naigeon M; Teixeira M; Escudier B; Flippot R; Albiges L
    Eur J Cancer; 2024 Apr; 201():113589. PubMed ID: 38382153
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. The Expression of Alamandine Receptor MrgD in Clear Cell Renal Cell Carcinoma Is Associated with a Worse Prognosis and Unfavorable Response to Antiangiogenic Therapy.
    Larrinaga G; Valdivia A; Arrieta-Aguirre I; Solano-Iturri JD; Ugalde-Olano A; Loizaga-Iriarte A; Santos-Martín A; Pérez-Fernández A; Angulo JC; López JI
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338778
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Epidemiology of and Risk Factors in Postoperative Complications from Robotically Assisted Laparoscopic Radical Prostatectomy in Contemporary National Surgical Quality Improvement Program Data.
    Homer A; Golijanin B; Schmitt P; Bhatt V; Pareek G; Hyams ES
    J Endourol; 2024 Mar; 38(3):270-275. PubMed ID: 38251639
    [No Abstract]    [Full Text] [Related]  

  • 4. CT radiomics to differentiate between Wilms tumor and clear cell sarcoma of the kidney in children.
    Deng Y; Wang H; He L
    BMC Med Imaging; 2024 Jan; 24(1):13. PubMed ID: 38182986
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Predicting recurrence and survival in patients with non-metastatic renal-cell carcinoma after nephrectomy: a prospective population-based study with multicenter validation.
    Wang Y; Xuan Y; Su B; Gao Y; Fan Y; Huang Q; Zhang P; Gu L; Niu S; Shen D; Li X; Wang B; Zhu Q; Ouyang Z; Xie J; Ma X
    Int J Surg; 2024 Feb; 110(2):820-831. PubMed ID: 38016139
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Quantitative Measurement on Contrast-Enhanced CT Distinguishes Small Clear Cell Renal Cell Carcinoma From Benign Renal tumors: A Multicenter Study.
    Luo S; Lin W; Wu J; Zhang W; Kui X; Lai S; Wei R; Pang X; Wang Y; He C; Liu J; Yang R
    Acad Radiol; 2024 Apr; 31(4):1460-1471. PubMed ID: 37945492
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Radiomics analysis based on single phase and different phase combinations of radiomics features from tri-phasic CT to distinguish renal oncocytoma from chromophobe renal cell carcinoma.
    Yang S; Jian Y; Yang F; Liu R; Zhang W; Wang J; Tan X; Wu J; Chen Y; Zhou X
    Abdom Radiol (NY); 2024 Jan; 49(1):182-191. PubMed ID: 37907684
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Immersive virtual reality and psychological well-being in adult chronic physical illness: systematic review.
    McGhee WRG; Doherty CJ; Graham-Wisener L; Fallis R; Stone C; Axiaq A; Dempster M
    BMJ Support Palliat Care; 2024 Feb; 14(1):14-24. PubMed ID: 37848219
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. The cycle effect quantified: reduced tumour uptake in subsequent cycles of [
    Siebinga H; Hendrikx JJMA; de Vries-Huizing DMV; Huitema ADR; de Wit-van der Veen BJ
    Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):820-827. PubMed ID: 37843598
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. ORM1 promotes tumor progression of kidney renal clear cell carcinoma (KIRC) through calr-mediated apoptosis.
    Yu G; Gao J; Hu W; Hu D; Wang W; Yang S; Gao J
    Sci Rep; 2023 Sep; 13(1):15687. PubMed ID: 37735575
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Prediction of Fuhrman nuclear grade for clear cell renal carcinoma by a multi-information fusion model that incorporates CT-based features of tumor and serum tumor associated material.
    Zhang Y; Sun Z; Ma H; Wang C; Zhang W; Liu J; Li M; Zhang Y; Guo H; Ba X
    J Cancer Res Clin Oncol; 2023 Nov; 149(17):15855-15865. PubMed ID: 37672076
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. The Association of kidney Function and Inflammatory Biomarkers with Epithelial Ovarian Cancer Risk.
    Hathaway CA; Townsend MK; Sklar EM; Thomas-Purcell KB; Terry KL; Trabert B; Tworoger SS
    Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1451-1457. PubMed ID: 37540498
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Evaluation of statin use and renal cell carcinoma risk identifies sex-specific associations with RCC subtypes.
    Michalek IM; Graff RE; Sanchez A; Choueiri TK; Cho E; Preston MA; Wilson KM
    Acta Oncol; 2023 Sep; 62(9):988-993. PubMed ID: 37482537
    [No Abstract]    [Full Text] [Related]  

  • 14. Enhancing information on stage at diagnosis for childhood cancer in Africa.
    Liu B; Abraham N; Chitsike I; Sylvie CGL; Kambugu J; Stévy NMA; Pondy AHO; Renner L; Parkin DM
    Pediatr Blood Cancer; 2023 Oct; 70(10):e30555. PubMed ID: 37432023
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. [Expression of GPNMB in renal eosinophilic tumors and its value in differential diagnosis].
    Wang Y; Hou MY; Fu Y; Meng K; Wu HY; Chen J; Xu YM; Shi J; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2023 Apr; 52(4):358-363. PubMed ID: 36973196
    [No Abstract]    [Full Text] [Related]  

  • 16. Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.
    Zhou S; Lu Y; Chen Y; Gan W
    Sci Rep; 2023 Mar; 13(1):4449. PubMed ID: 36932108
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Non-occupational physical activity and risk of cardiovascular disease, cancer and mortality outcomes: a dose-response meta-analysis of large prospective studies.
    Garcia L; Pearce M; Abbas A; Mok A; Strain T; Ali S; Crippa A; Dempsey PC; Golubic R; Kelly P; Laird Y; McNamara E; Moore S; de Sa TH; Smith AD; Wijndaele K; Woodcock J; Brage S
    Br J Sports Med; 2023 Aug; 57(15):979-989. PubMed ID: 36854652
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Stability of renal parenchymal volume and function during active surveillance of renal oncocytoma patients.
    Menon AR; Cheema A; Hou S; Attwood KM; White T; James G; Xu B; Petroziello M; Roche CL; Kurenov S; Kauffman EC
    Urol Oncol; 2023 Apr; 41(4):208.e15-208.e23. PubMed ID: 36842877
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation.
    Qu J; Zhang Q; Song X; Jiang H; Ma H; Li W; Wang X
    BMC Med Imaging; 2023 Jan; 23(1):16. PubMed ID: 36707788
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Angiomyolipoma of the kidney-Clinicopathological analysis of 52 cases.
    Fejes Z; Sánta F; Jenei A; Király IE; Varga L; Kuthi L
    Pathol Oncol Res; 2022; 28():1610831. PubMed ID: 36699622
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 13.